Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Should symptomatic menopausal women be offered hormone therapy?
Lobo RA, Bélisle S, Creasman WT, Frankel NR, Goodman NF, Hall JE, Ivey SL, Kingsberg S, Langer R, Lehman R, McArthur DB, Montgomery-Rice V, Notelovitz M, Packin GS, Rebar RW, Rousseau M, Schenken RS, Schneider DL, Sherif K, Wysocki S. Lobo RA, et al. Among authors: creasman wt. MedGenMed. 2006;8(3):40. MedGenMed. 2006. PMID: 17410686 Free PMC article. Review.
Should symptomatic menopausal women be offered hormone therapy?
Lobo RA, Bélisle S, Creasman WT, Frankel NR, Goodman NE, Hall JE, Ivey SL, Kingsberg S, Langer R, Lehman R, McArthur DB, Montgomery-Rice V, Notelovitz M, Packin GS, Rebar RW, Rousseau M, Schenken RS, Schneider DL, Sherif K, Wysocki S. Lobo RA, et al. Among authors: creasman wt. MedGenMed. 2006;8(2):1 p preceding 35. MedGenMed. 2006. PMID: 17048337 Review.
Breast cancer: the role of hormone therapy.
Creasman WT. Creasman WT. Semin Reprod Med. 2005 May;23(2):167-71. doi: 10.1055/s-2005-869484. Semin Reprod Med. 2005. PMID: 15852202 Review.
Hormone replacement therapy after cancers.
Creasman WT. Creasman WT. Curr Opin Oncol. 2005 Sep;17(5):493-9. doi: 10.1097/01.cco.0000174034.62032.08. Curr Opin Oncol. 2005. PMID: 16093802 Review.
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
Tewari KS, Sill MW, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, DiSaia PJ, Copeland LJ, Creasman WT, Stehman FB, Brady MF, Burger RA, Thigpen JT, Birrer MJ, Waggoner SE, Moore DH, Look KY, Koh WJ, Monk BJ. Tewari KS, et al. Among authors: creasman wt. Lancet. 2017 Oct 7;390(10103):1654-1663. doi: 10.1016/S0140-6736(17)31607-0. Epub 2017 Jul 27. Lancet. 2017. PMID: 28756902 Free PMC article. Clinical Trial.
Vaginal cancers.
Creasman WT. Creasman WT. Curr Opin Obstet Gynecol. 2005 Feb;17(1):71-6. doi: 10.1097/00001703-200502000-00013. Curr Opin Obstet Gynecol. 2005. PMID: 15711415 Review.
262 results